Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) — Financial Flexibility Index
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a Financial Flexibility Index of 0.05x as of December 2025. Free cash flow of CN¥2.18 Billion (operating CF CN¥1.84 Billion minus capex CN¥330.65 Million) represents 0% of total liabilities (CN¥43.39 Billion). Check how aggressively does Guangzhou Baiyunshan Pharmaceutical Hold reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Financial Flexibility Index (2000–2025)
Historical Financial Flexibility Index trend for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd across 26 annual periods. For the full cash flow conversion analysis, see Guangzhou Baiyunshan Pharmaceutical Hold cash conversion from operations.
Annual Financial Flexibility Index for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2000–2025)
Year-by-year free cash flow to debt coverage for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. Explore Guangzhou Baiyunshan Pharmaceutical Hold debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.03x | CN¥1.50 Billion | CN¥260.23 Million | CN¥43.39 Billion | ▼ -66.8% |
| 2024 | 0.10x | CN¥4.57 Billion | CN¥3.44 Billion | CN¥43.91 Billion | ▼ -23.9% |
| 2023 | 0.14x | CN¥5.73 Billion | CN¥4.10 Billion | CN¥41.91 Billion | ▼ -33.1% |
| 2022 | 0.20x | CN¥8.38 Billion | CN¥7.00 Billion | CN¥41.03 Billion | ▲ +2.6% |
| 2021 | 0.20x | CN¥6.93 Billion | CN¥5.67 Billion | CN¥34.79 Billion | ▲ +329.9% |
| 2020 | 0.05x | CN¥1.46 Billion | CN¥585.19 Million | CN¥31.55 Billion | ▼ -80.7% |
| 2019 | 0.24x | CN¥7.42 Billion | CN¥5.02 Billion | CN¥30.90 Billion | ▲ +19.5% |
| 2018 | 0.20x | CN¥5.70 Billion | CN¥5.22 Billion | CN¥28.34 Billion | ▼ -10.4% |
| 2017 | 0.22x | CN¥2.03 Billion | CN¥1.83 Billion | CN¥9.05 Billion | ▼ -30.8% |
| 2016 | 0.32x | CN¥2.67 Billion | CN¥2.44 Billion | CN¥8.24 Billion | ▼ -5.2% |
| 2015 | 0.34x | CN¥2.46 Billion | CN¥1.94 Billion | CN¥7.19 Billion | ▲ +1.1% |
| 2014 | 0.34x | CN¥2.12 Billion | CN¥1.76 Billion | CN¥6.25 Billion | ▲ +4.7% |
| 2013 | 0.32x | CN¥1.69 Billion | CN¥1.34 Billion | CN¥5.23 Billion | ▲ +16.3% |
| 2012 | 0.28x | CN¥559.14 Million | CN¥506.53 Million | CN¥2.01 Billion | ▲ +319.3% |
| 2011 | -0.13x | CN¥-121.19 Million | CN¥-180.05 Million | CN¥956.09 Million | ▼ -167.7% |
| 2010 | 0.19x | CN¥156.37 Million | CN¥73.17 Million | CN¥835.05 Million | ▼ -70.8% |
| 2009 | 0.64x | CN¥526.95 Million | CN¥439.39 Million | CN¥820.92 Million | ▲ +337.0% |
| 2008 | 0.15x | CN¥133.09 Million | CN¥6.10 Million | CN¥905.99 Million | ▼ -14.2% |
| 2007 | 0.17x | CN¥498.43 Million | CN¥375.74 Million | CN¥2.91 Billion | ▲ +224.9% |
| 2006 | 0.05x | CN¥129.33 Million | CN¥38.88 Million | CN¥2.46 Billion | ▼ -55.4% |
| 2005 | 0.12x | CN¥270.68 Million | CN¥146.32 Million | CN¥2.29 Billion | ▼ -40.9% |
| 2004 | 0.20x | CN¥509.23 Million | CN¥200.54 Million | CN¥2.55 Billion | ▲ +17.1% |
| 2003 | 0.17x | CN¥360.35 Million | CN¥-6.83 Million | CN¥2.11 Billion | ▼ -12.8% |
| 2002 | 0.20x | CN¥342.71 Million | CN¥169.01 Million | CN¥1.75 Billion | ▼ -7.9% |
| 2001 | 0.21x | CN¥300.59 Million | CN¥140.15 Million | CN¥1.41 Billion | ▼ -26.1% |
| 2000 | 0.29x | CN¥450.48 Million | CN¥286.95 Million | CN¥1.57 Billion | — |